Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
NCT05597878Phase 3Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2023
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ketamine and ketorolac in postoperative pain (2 cohorts), sponsored by Wake Forest University Health Sciences. Primary endpoint: Change in Pain Scores. Started Apr 2023; status: terminated.
02
Drugs
ketamineketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05597878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05597878.